FAQ
Log In
Sunday 11th December 2016
News
 › 
 › 

Gaviscon firm fined

15th October 2010

Reckitt Benckiser has agreed to pay a £10.2m fine after admitting to abusing its market position for the supply of heartburn drug Gaviscon.

The Office of Fair Trading (OFT) had accused the household products firm in February of restricting competition in the supply of heartburn medicines to the NHS. The OFT said the fine had been reduced from £12m, reflecting Reckitt's admission and early co-operation with the watchdog but it still remained the highest penalty it had imposed in an abuse-of-dominance case.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016